Ensuring Drug Security Forum

The challenges Russia has faced in recent years have shown that the development, registration, and commercialization of medicines can be significantly accelerated without compromising safety and quality. This experience is being actively used today. Regulatory changes are not only taking place in Russia, but throughout the entire Eurasian Economic Union. The general processes associated with the circulation of drugs are functioning and continue to be refined. A system to monitor the movement of medicines has been introduced, which makes it possible to control the supply of drugs, verify the availability of medicines in the regions, track the journey of products from the manufacturing plant to the pharmacy and the hospital, and guarantee its authenticity. Another important aspect is the growth of e-commerce in the drug market and the need for comprehensive control to prevent the threat of illegal sales of drugs to the public. The supervisory authorities continue to focus on the quality and safety of medical care in primary healthcare and whether drug prescriptions are provided in accordance with clinical recommendations. What advantages does a unified market for drugs provide for all participants in the pharmaceutical market? What prospects exist for the development and use of a system to monitor the movement of medicines? How is transparency and safety ensured in the online pharmaceuticals sector and what prospects does it offer for patient comfort? What is the role of drug therapy in clinical guidelines? Would the standardization of processes affect the quality of medical care?

Moderator
Alla Samoylova, Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Alla Samoylova

Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Born in Cheboksary.
1990: Graduated from the Chuvash State University named after I. N. Ulyanov with a degree in medicine.
2002: Awarded with the badge “Excellent Worker of Public Health”.
2007: Honored doctor of the Chuvash Republic.
2010: Doctor of Science in medicine.
2012: Professor of obstetrics and gynecology.
1987-1990 – nurse, obstetrician-gynecologist at the industrial hospitals in Cheboksary.
1990-1993 – Full-time postgraduate study at Chuvash State University.
1993-1994 - Assistant at the Obstetrics and Gynecology Department of the Chuvash State University.
1994-2012 – Chief Doctor of the Presidential Perinatal Center of the Ministry of Health and social development of the Chuvash Republic.
2010-2017 – Head of the Department of Obstetrics and Gynecology named after G. M. Vorontsova, of the Chuvash State University.
2012-2015 – Deputy Chair at the Cabinet of Ministers of the Chuvash Republic - Minister of Health and Social Development of the Chuvash Republic.
2015-2017 – Minister of Health of the Chuvash Republic.
2018-2019 – Adviser to the Head of the Federal Service for Surveillance in Healthcare.
2019-2020 – Head of the Department of State Control of Implementation of State Healthcare Programs, the Federal Service for Surveillance in Healthcare.
2020 – Director of the Project Activities Department, the Ministry of Health of the Russian Federation.
Since April 10, 2020 - Head of the Federal Service for Surveillance in Healthcare.

Panellists
Dmitry Alkhazov, Chief Executive Officer, Advanced Technologies Development Center (ATDC)
Dmitriy Galkin, Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation
Sergey Glagolev, Deputy Minister of Health of the Russian Federation
Guvenc Kockaya, General Director, Econix Research, Analysis and Consulting Inc.
Vitaliy Omelyanovskiy, General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Aleksandr Petrov, Deputy, member of the State Duma Committee on Health Protection of the Federal Assembly of the Russian Federation
Andrey Sarana, First Deputy Chairman of the Health Committee of St. Petersburg

Dmitry Alkhazov

Chief Executive Officer, Advanced Technologies Development Center (ATDC)

Dmitriy Galkin

Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation

Sergey Glagolev

Deputy Minister of Health of the Russian Federation

Vitaliy Omelyanovskiy

General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.

Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.

Aleksandr Petrov

Deputy, member of the State Duma Committee on Health Protection of the Federal Assembly of the Russian Federation

Front row participants
Victor Dmitriev, General Manager, Association of Russian Pharmaceutical Manufacturers; Chairman of the Public Council under the Federal Service for Surveillance in Healthcare
Vasily Ignatiev, General Director, R-Pharm

Victor Dmitriev

General Manager, Association of Russian Pharmaceutical Manufacturers; Chairman of the Public Council under the Federal Service for Surveillance in Healthcare

CEO, Association of Russian Pharmaceuticals Manufacturers, member of the Board, Russian Union of Industrialists and Entrepreneurs, member of the Council, Chamber of Trade and Industry of the Russian Federation
PhD in Medicine, a degree from I.M. Sechenov First Moscow Institute of Medicine.
In 2002, he co-founded the Association of Russian Pharmaceuticals Manufacturers and led it until 2004. From 2004 to 2007, he was Deputy Director of Federal State-Owned Institution Research Center for Testing of Medical Applications under the Russian Service for Supervision of Healthcare. In October 2007, a general meeting of the Association once again elected Victor Dmitriev its CEO.
Founded in 2002, the Association of Russian Pharmaceuticals Manufacturers includes leading Russian pharmaceutical companies with around 75% of Russia’s medicine output, more than 40% of exports, and more than 80% of domestically produced medicines for the Essential Medicines Provision Program. The Association’s mission is to develop the Russian pharmaceutical industry to ensure the necessary supplies of modern, quality, and affordable medicines to the public.

Vasily Ignatiev

General Director, R-Pharm

Born in Moscow, Russia on 27 November 1968.
Ignatiev holds an MD – diploma with honours from the I.M. Sechenov First Moscow State Medical University. Expert in clinical pharmacology. Holds a Candidate of Medical Research Degree. Studied at Columbia University College of Physicians and Surgeons (New York, USA). Holds MBA degrees from Moscow International Higher Business School MIRBIS and London Guildhall University (now part of the London Metropolitan University).
For 7 years Ignatiev worked in the Russian branch of the international pharmaceutical company Bristol-Myers Squibb in the positions of Product Manager, Franchise Manager, Marketing Director.
For 5 years Ignatiev served in the Russian branch of the international pharmaceutical company AstraZeneca in the leading positions of Marketing Director and Sales Director.
In 2008, Ignatiev was appointed Director for Business Development in CJSC R-Pharm, a Russian pharmaceutical company. And now he is the Chief Executive Officer.
In 2018 Ignatiev was elected to become Vice Chair of the Board of the Association of International Pharmaceutical Manufacturers.